505 related articles for article (PubMed ID: 27625395)
21. c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.
Martinez-Fernandez A; Nelson TJ; Ikeda Y; Terzic A
J Cardiovasc Transl Res; 2010 Feb; 3(1):13-23. PubMed ID: 20221419
[TBL] [Abstract][Full Text] [Related]
22. ESRRB plays a crucial role in the promotion of porcine cell reprograming.
Yang F; Ren Y; Li H; Wang H
J Cell Physiol; 2018 Feb; 233(2):1601-1611. PubMed ID: 28636277
[TBL] [Abstract][Full Text] [Related]
23. BDE-209 inhibits pluripotent genes expression and induces apoptosis in human embryonic stem cells.
Du L; Sun W; Zhang H; Chen D
J Appl Toxicol; 2016 May; 36(5):659-68. PubMed ID: 26206603
[TBL] [Abstract][Full Text] [Related]
24. Analyzing bovine OCT4 and NANOG enhancer activity in pluripotent stem cells using fluorescent protein reporters.
Huang D; Wang L; Talbot NC; Huang C; Pu L; Zhao X; Tian X; Zhang M; Tang Y
PLoS One; 2018; 13(10):e0203923. PubMed ID: 30289916
[TBL] [Abstract][Full Text] [Related]
25. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
Gunaratne PH
Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
[TBL] [Abstract][Full Text] [Related]
26. Molecular coupling of Tsix regulation and pluripotency.
Navarro P; Oldfield A; Legoupi J; Festuccia N; Dubois A; Attia M; Schoorlemmer J; Rougeulle C; Chambers I; Avner P
Nature; 2010 Nov; 468(7322):457-60. PubMed ID: 21085182
[TBL] [Abstract][Full Text] [Related]
27. Induced pluripotent stem cells from goat fibroblasts.
Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
[TBL] [Abstract][Full Text] [Related]
28. Differentiation-independent fluctuation of pluripotency-related transcription factors and other epigenetic markers in embryonic stem cell colonies.
Sustáčková G; Legartová S; Kozubek S; Stixová L; Pacherník J; Bártová E
Stem Cells Dev; 2012 Mar; 21(5):710-20. PubMed ID: 21609209
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells.
Koga C; Kobayashi S; Nagano H; Tomimaru Y; Hama N; Wada H; Kawamoto K; Eguchi H; Konno M; Ishii H; Umeshita K; Doki Y; Mori M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S591-600. PubMed ID: 24740829
[TBL] [Abstract][Full Text] [Related]
30. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
31. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
[TBL] [Abstract][Full Text] [Related]
32. Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review.
van Schaijik B; Davis PF; Wickremesekera AC; Tan ST; Itinteang T
J Clin Pathol; 2018 Jan; 71(1):88-91. PubMed ID: 29180509
[TBL] [Abstract][Full Text] [Related]
33. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
34. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
35. Klf4 could be activated by Pou5f3/Stat3 to induce the expression of Nanog in Japanese flounder.
Sun Y; Liu J; Wang B; Liu X; Du X; Liu Y; Zhang Q
Gene; 2019 Mar; 687():56-63. PubMed ID: 30447341
[TBL] [Abstract][Full Text] [Related]
36. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
[TBL] [Abstract][Full Text] [Related]
37. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
38. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
[TBL] [Abstract][Full Text] [Related]
39. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
[TBL] [Abstract][Full Text] [Related]
40. Stem cell markers in glioma progression and recurrence.
Hattermann K; Flüh C; Engel D; Mehdorn HM; Synowitz M; Mentlein R; Held-Feindt J
Int J Oncol; 2016 Nov; 49(5):1899-1910. PubMed ID: 27600094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
